Home/Arthrosi Therapeutics/Litain Yeh, PhD
LY

Litain Yeh, PhD

Co-Founder & Chief Executive Officer

Arthrosi Therapeutics

Therapeutic Areas

Arthrosi Therapeutics Pipeline

DrugIndicationPhase
AR882 (Pozdeutinurad)Gout and Tophaceous GoutPhase 3